Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Key residues defining the mu-opioid receptor binding pocket: a site-directed mutagenesis study.

Mansour A, Taylor LP, Fine JL, Thompson RC, Hoversten MT, Mosberg HI, Watson SJ, Akil H.

J Neurochem. 1997 Jan;68(1):344-53.

2.

A single residue, Lys108, of the delta-opioid receptor prevents the mu-opioid-selective ligand [D-Ala2,N-MePhe4,Gly-ol5]enkephalin from binding to the delta-opioid receptor.

Minami M, Nakagawa T, Seki T, Onogi T, Aoki Y, Katao Y, Katsumata S, Satoh M.

Mol Pharmacol. 1996 Nov;50(5):1413-22.

PMID:
8913373
3.

Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.

Zhao GM, Qian X, Schiller PW, Szeto HH.

J Pharmacol Exp Ther. 2003 Dec;307(3):947-54. Epub 2003 Oct 8.

4.

DAMGO recognizes four residues in the third extracellular loop to discriminate between mu- and kappa-opioid receptors.

Seki T, Minami M, Nakagawa T, Ienaga Y, Morisada A, Satoh M.

Eur J Pharmacol. 1998 Jun 5;350(2-3):301-10.

PMID:
9696421
5.

Opioid peptide receptor studies. 9. Identification of a novel non-mu- non-delta-like opioid peptide binding site in rat brain.

Ni Q, Xu H, Partilla JS, Rice KC, Matecka D, Calderon SN, Porreca F, Lai J, Schmidhammer H, Krassnig R, Rothman RB.

Peptides. 1998;19(6):1079-90.

PMID:
9700759
6.
7.

Opioid peptide receptor studies, 11: involvement of Tyr148, Trp318 and His319 of the rat mu-opioid receptor in binding of mu-selective ligands.

Xu H, Lu YF, Partilla JS, Zheng QX, Wang JB, Brine GA, Carroll FI, Rice KC, Chen KX, Chi ZQ, Rothman RB.

Synapse. 1999 Apr;32(1):23-8.

PMID:
10188634
8.

Mechanism of clocinnamox blockade of opioid receptors: evidence from in vitro and ex vivo binding and behavioral assays.

Zernig G, Burke T, Lewis JW, Woods JH.

J Pharmacol Exp Ther. 1996 Oct;279(1):23-31.

PMID:
8858971
9.

Delta and mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa: cloning, heterologous expression, and pharmacological characterization.

Bradford CS, Walthers EA, Stanley DJ, Baugh MM, Moore FL.

Gen Comp Endocrinol. 2006 May 1;146(3):275-90. Epub 2005 Dec 20.

PMID:
16375901
10.

Opioid peptide receptor studies. 3. Interaction of opioid peptides and other drugs with four subtypes of the kappa 2 receptor in guinea pig brain.

Ni Q, Xu H, Partilla JS, de Costa BR, Rice KC, Kayakiri H, Rothman RB.

Peptides. 1995;16(6):1083-95.

PMID:
8532593
11.

Opioid peptide receptor studies. 7. The methylfentanyl congener RTI-4614-4 and its four enantiomers bind to different domains of the rat mu opioid receptor.

Lu YF, Xu H, Liu-Chen LY, Chen C, Partilla JS, Brine GA, Carroll FI, Rice KC, Lai J, Porreca F, Sadee W, Rothman RB.

Synapse. 1998 Feb;28(2):117-24.

PMID:
9450512
12.

Bioactivity of new mu and delta opioid peptides.

Capasso A.

Med Chem. 2007 Sep;3(5):480-7.

PMID:
17897075
13.

Characterization and distribution of a cloned rat mu-opioid receptor.

Bunzow JR, Zhang G, Bouvier C, Saez C, Ronnekleiv OK, Kelly MJ, Grandy DK.

J Neurochem. 1995 Jan;64(1):14-24.

PMID:
7798908
14.

Mutation of human mu opioid receptor extracellular "disulfide cysteine" residues alters ligand binding but does not prevent receptor targeting to the cell plasma membrane.

Zhang P, Johnson PS, Zöllner C, Wang W, Wang Z, Montes AE, Seidleck BK, Blaschak CJ, Surratt CK.

Brain Res Mol Brain Res. 1999 Oct 1;72(2):195-204.

PMID:
10529478
15.
16.
17.

Presence in neuroblastoma cells of a mu 3 receptor with selectivity for opiate alkaloids but without affinity for opioid peptides.

Cruciani RA, Dvorkin B, Klinger HP, Makman MH.

Brain Res. 1994 Dec 26;667(2):229-37.

PMID:
7697360
18.

Naloxone activation of mu-opioid receptors mutated at a histidine residue lining the opioid binding cavity.

Spivak CE, Beglan CL, Seidleck BK, Hirshbein LD, Blaschak CJ, Uhl GR, Surratt CK.

Mol Pharmacol. 1997 Dec;52(6):983-92.

19.

Functional role of the spatial proximity of Asp114(2.50) in TMH 2 and Asn332(7.49) in TMH 7 of the mu opioid receptor.

Xu W, Ozdener F, Li JG, Chen C, de Riel JK, Weinstein H, Liu-Chen LY.

FEBS Lett. 1999 Mar 26;447(2-3):318-24.

20.

Supplemental Content

Support Center